{"entity":{"type":"insider","cik":"0001503559","url":"/insider/0001503559","json_url":"/insider/0001503559.json","name":"Flagship Ventures Fund IV, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":92,"n_filings":21,"first":"2014-02-13","last":"2023-07-13","span_basis":"filed_date"},"name_variants":[{"name":"Flagship Ventures Fund IV, L.P.","source":"filing","n_filings":21,"first_seen":"2014-02-13","last_seen":"2023-07-13"}],"transactions":[{"id":8576320,"accession":"0000950170-23-032871","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-23-032871","line_url":"/filing/0000950170-23-032871#line-3","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Evelo Biosciences, Inc.","issuer_ticker":"EVLO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"AFEYAN NOUBAR; Flagship Pioneering Fund VII General Partner LLC; Flagship Pioneering Fund VII, L.P.; Flagship Pioneering Inc.; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV, L.P.; Nutritional Health LTP Fund General Partner LLC; Nutritional Health LTP Fund, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3246753.0,"shares_display":"3,246,753","price_per_share":2.31,"price_display":"2.31","price_state":"stated","total_value":7499999.43,"total_display":"7,499,999.43","shares_owned_after":3931685.0,"shares_owned_after_display":"3,931,685","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-07-11","filed_date":"2023-07-13","scope":"insider"},{"id":8576316,"accession":"0000950170-23-032871","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-032871","line_url":"/filing/0000950170-23-032871#line-2","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Evelo Biosciences, Inc.","issuer_ticker":"EVLO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"AFEYAN NOUBAR; Flagship Pioneering Fund VII General Partner LLC; Flagship Pioneering Fund VII, L.P.; Flagship Pioneering Inc.; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV, L.P.; Nutritional Health LTP Fund General Partner LLC; Nutritional Health LTP Fund, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1082251.0,"shares_display":"1,082,251","price_per_share":2.31,"price_display":"2.31","price_state":"stated","total_value":2499999.81,"total_display":"2,499,999.81","shares_owned_after":1493241.0,"shares_owned_after_display":"1,493,241","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-07-11","filed_date":"2023-07-13","scope":"insider"},{"id":8576311,"accession":"0000950170-23-032871","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-032871","line_url":"/filing/0000950170-23-032871#line-1","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Evelo Biosciences, Inc.","issuer_ticker":"EVLO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"AFEYAN NOUBAR; Flagship Pioneering Fund VII General Partner LLC; Flagship Pioneering Fund VII, L.P.; Flagship Pioneering Inc.; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV, L.P.; Nutritional Health LTP Fund General Partner LLC; Nutritional Health LTP Fund, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1082251.0,"shares_display":"1,082,251","price_per_share":2.31,"price_display":"2.31","price_state":"stated","total_value":2499999.81,"total_display":"2,499,999.81","shares_owned_after":1461795.0,"shares_owned_after_display":"1,461,795","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-07-11","filed_date":"2023-07-13","scope":"insider"},{"id":6645696,"accession":"0000899243-22-033703","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-22-033703","line_url":"/filing/0000899243-22-033703#line-5","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Axcella Health Inc.","issuer_ticker":"AXLA","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Opportunities Fund I General Partner LLC; Flagship Ventures Opportunities Fund I, L.P.; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund IV General Partner LLC; AFEYAN NOUBAR","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3048780.0,"shares_display":"3,048,780","price_per_share":1.64,"price_display":"1.64","price_state":"stated","total_value":4999999.2,"total_display":"4,999,999.20","shares_owned_after":3048780.0,"shares_owned_after_display":"3,048,780","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-13","filed_date":"2022-10-17","scope":"insider"},{"id":6645693,"accession":"0000899243-22-033703","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-033703","line_url":"/filing/0000899243-22-033703#line-4","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Axcella Health Inc.","issuer_ticker":"AXLA","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Opportunities Fund I General Partner LLC; Flagship Ventures Opportunities Fund I, L.P.; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund IV General Partner LLC; AFEYAN NOUBAR","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2757333.0,"shares_display":"2,757,333","price_per_share":1.64,"price_display":"1.64","price_state":"stated","total_value":4522026.12,"total_display":"4,522,026.12","shares_owned_after":14101638.0,"shares_owned_after_display":"14,101,638","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-13","filed_date":"2022-10-17","scope":"insider"},{"id":6645691,"accession":"0000899243-22-033703","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-033703","line_url":"/filing/0000899243-22-033703#line-3","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Axcella Health Inc.","issuer_ticker":"AXLA","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Opportunities Fund I General Partner LLC; Flagship Ventures Opportunities Fund I, L.P.; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund IV General Partner LLC; AFEYAN NOUBAR","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2743902.0,"shares_display":"2,743,902","price_per_share":1.64,"price_display":"1.64","price_state":"stated","total_value":4499999.28,"total_display":"4,499,999.28","shares_owned_after":11344305.0,"shares_owned_after_display":"11,344,305","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-13","filed_date":"2022-10-17","scope":"insider"},{"id":6645688,"accession":"0000899243-22-033703","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-033703","line_url":"/filing/0000899243-22-033703#line-2","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Axcella Health Inc.","issuer_ticker":"AXLA","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Opportunities Fund I General Partner LLC; Flagship Ventures Opportunities Fund I, L.P.; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund IV General Partner LLC; AFEYAN NOUBAR","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":919111.0,"shares_display":"919,111","price_per_share":1.64,"price_display":"1.64","price_state":"stated","total_value":1507342.04,"total_display":"1,507,342.04","shares_owned_after":6299611.0,"shares_owned_after_display":"6,299,611","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-13","filed_date":"2022-10-17","scope":"insider"},{"id":6645686,"accession":"0000899243-22-033703","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-033703","line_url":"/filing/0000899243-22-033703#line-1","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Axcella Health Inc.","issuer_ticker":"AXLA","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Opportunities Fund I General Partner LLC; Flagship Ventures Opportunities Fund I, L.P.; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund IV General Partner LLC; AFEYAN NOUBAR","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":914634.0,"shares_display":"914,634","price_per_share":1.64,"price_display":"1.64","price_state":"stated","total_value":1499999.76,"total_display":"1,499,999.76","shares_owned_after":5380500.0,"shares_owned_after_display":"5,380,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-13","filed_date":"2022-10-17","scope":"insider"},{"id":6386114,"accession":"0000899243-22-020533","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-22-020533","line_url":"/filing/0000899243-22-020533#line-5","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Evelo Biosciences, Inc.","issuer_ticker":"EVLO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Fund IV General Partner LLC; Nutritional Health LTP Fund, L.P.; Flagship Ventures Opportunities Fund I, L.P.; Flagship Ventures Fund IV-Rx, L.P.; Nutritional Health LTP Fund General Partner LLC; AFEYAN NOUBAR; Flagship Pioneering Inc.; Flagship Ventures Opportunities Fund I General Partner LLC; Flagship Ventures Fund IV, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13698630.0,"shares_display":"13,698,630","price_per_share":1.46,"price_display":"1.46","price_state":"stated","total_value":19999999.8,"total_display":"19,999,999.80","shares_owned_after":13698630.0,"shares_owned_after_display":"13,698,630","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-27","filed_date":"2022-06-01","scope":"insider"},{"id":6386113,"accession":"0000899243-22-020533","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-020533","line_url":"/filing/0000899243-22-020533#line-4","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Evelo Biosciences, Inc.","issuer_ticker":"EVLO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Fund IV General Partner LLC; Nutritional Health LTP Fund, L.P.; Flagship Ventures Opportunities Fund I, L.P.; Flagship Ventures Fund IV-Rx, L.P.; Nutritional Health LTP Fund General Partner LLC; AFEYAN NOUBAR; Flagship Pioneering Inc.; Flagship Ventures Opportunities Fund I General Partner LLC; Flagship Ventures Fund IV, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6849315.0,"shares_display":"6,849,315","price_per_share":1.46,"price_display":"1.46","price_state":"stated","total_value":9999999.9,"total_display":"9,999,999.90","shares_owned_after":8219791.0,"shares_owned_after_display":"8,219,791","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-27","filed_date":"2022-06-01","scope":"insider"},{"id":6386110,"accession":"0000899243-22-020533","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-020533","line_url":"/filing/0000899243-22-020533#line-3","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Evelo Biosciences, Inc.","issuer_ticker":"EVLO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Fund IV General Partner LLC; Nutritional Health LTP Fund, L.P.; Flagship Ventures Opportunities Fund I, L.P.; Flagship Ventures Fund IV-Rx, L.P.; Nutritional Health LTP Fund General Partner LLC; AFEYAN NOUBAR; Flagship Pioneering Inc.; Flagship Ventures Opportunities Fund I General Partner LLC; Flagship Ventures Fund IV, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4383561.0,"shares_display":"4,383,561","price_per_share":1.46,"price_display":"1.46","price_state":"stated","total_value":6399999.06,"total_display":"6,399,999.06","shares_owned_after":7590873.0,"shares_owned_after_display":"7,590,873","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-27","filed_date":"2022-06-01","scope":"insider"},{"id":6386108,"accession":"0000899243-22-020533","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-020533","line_url":"/filing/0000899243-22-020533#line-2","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Evelo Biosciences, Inc.","issuer_ticker":"EVLO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Fund IV General Partner LLC; Nutritional Health LTP Fund, L.P.; Flagship Ventures Opportunities Fund I, L.P.; Flagship Ventures Fund IV-Rx, L.P.; Nutritional Health LTP Fund General Partner LLC; AFEYAN NOUBAR; Flagship Pioneering Inc.; Flagship Ventures Opportunities Fund I General Partner LLC; Flagship Ventures Fund IV, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1369863.0,"shares_display":"1,369,863","price_per_share":1.46,"price_display":"1.46","price_state":"stated","total_value":1999999.98,"total_display":"1,999,999.98","shares_owned_after":5495324.0,"shares_owned_after_display":"5,495,324","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-27","filed_date":"2022-06-01","scope":"insider"},{"id":6386104,"accession":"0000899243-22-020533","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-020533","line_url":"/filing/0000899243-22-020533#line-1","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Evelo Biosciences, Inc.","issuer_ticker":"EVLO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Fund IV General Partner LLC; Nutritional Health LTP Fund, L.P.; Flagship Ventures Opportunities Fund I, L.P.; Flagship Ventures Fund IV-Rx, L.P.; Nutritional Health LTP Fund General Partner LLC; AFEYAN NOUBAR; Flagship Pioneering Inc.; Flagship Ventures Opportunities Fund I General Partner LLC; Flagship Ventures Fund IV, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1095890.0,"shares_display":"1,095,890","price_per_share":1.46,"price_display":"1.46","price_state":"stated","total_value":1599999.4,"total_display":"1,599,999.40","shares_owned_after":1887419.0,"shares_owned_after_display":"1,887,419","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-27","filed_date":"2022-06-01","scope":"insider"},{"id":6691040,"accession":"0000899243-22-011535","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-011535","line_url":"/filing/0000899243-22-011535#line-3","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Axcella Health Inc.","issuer_ticker":"AXLA","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Opportunities Fund I General Partner LLC; Flagship Ventures Fund IV, L.P.; AFEYAN NOUBAR; Flagship Ventures Opportunities Fund I, L.P.; Flagship Ventures Fund IV-Rx, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3791623.0,"shares_display":"3,791,623","price_per_share":1.91,"price_display":"1.91","price_state":"stated","total_value":7241999.93,"total_display":"7,241,999.93","shares_owned_after":8600403.0,"shares_owned_after_display":"8,600,403","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-16","filed_date":"2022-03-18","scope":"insider"},{"id":6691038,"accession":"0000899243-22-011535","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-011535","line_url":"/filing/0000899243-22-011535#line-2","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Axcella Health Inc.","issuer_ticker":"AXLA","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Opportunities Fund I General Partner LLC; Flagship Ventures Fund IV, L.P.; AFEYAN NOUBAR; Flagship Ventures Opportunities Fund I, L.P.; Flagship Ventures Fund IV-Rx, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1579843.0,"shares_display":"1,579,843","price_per_share":1.91,"price_display":"1.91","price_state":"stated","total_value":3017500.13,"total_display":"3,017,500.13","shares_owned_after":4465866.0,"shares_owned_after_display":"4,465,866","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-16","filed_date":"2022-03-18","scope":"insider"},{"id":6691036,"accession":"0000899243-22-011535","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-011535","line_url":"/filing/0000899243-22-011535#line-1","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Axcella Health Inc.","issuer_ticker":"AXLA","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Opportunities Fund I General Partner LLC; Flagship Ventures Fund IV, L.P.; AFEYAN NOUBAR; Flagship Ventures Opportunities Fund I, L.P.; Flagship Ventures Fund IV-Rx, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":947905.0,"shares_display":"947,905","price_per_share":1.91,"price_display":"1.91","price_state":"stated","total_value":1810498.55,"total_display":"1,810,498.55","shares_owned_after":2004657.0,"shares_owned_after_display":"2,004,657","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-16","filed_date":"2022-03-18","scope":"insider"},{"id":5391706,"accession":"0000899243-21-013179","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-013179","line_url":"/filing/0000899243-21-013179#line-3","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Rubius Therapeutics, Inc.","issuer_ticker":"RUBY","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"AFEYAN NOUBAR; Flagship Ventures Fund V, L.P.; Flagship Ventures Fund V General Partner LLC; Flagship Ventures Opportunities Fund I General Partner LLC; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV, L.P.; Flagship Ventures Opportunities Fund I, L.P.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":70000.0,"shares_display":"70,000","price_per_share":29.0,"price_display":"29.00","price_state":"stated","total_value":2030000.0,"total_display":"2,030,000.00","shares_owned_after":15393593.0,"shares_owned_after_display":"15,393,593","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-19","filed_date":"2021-03-23","scope":"insider"},{"id":5391701,"accession":"0000899243-21-013179","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-013179","line_url":"/filing/0000899243-21-013179#line-2","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Rubius Therapeutics, Inc.","issuer_ticker":"RUBY","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"AFEYAN NOUBAR; Flagship Ventures Fund V, L.P.; Flagship Ventures Fund V General Partner LLC; Flagship Ventures Opportunities Fund I General Partner LLC; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV, L.P.; Flagship Ventures Opportunities Fund I, L.P.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":70000.0,"shares_display":"70,000","price_per_share":29.0,"price_display":"29.00","price_state":"stated","total_value":2030000.0,"total_display":"2,030,000.00","shares_owned_after":5859414.0,"shares_owned_after_display":"5,859,414","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-19","filed_date":"2021-03-23","scope":"insider"},{"id":5391698,"accession":"0000899243-21-013179","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-013179","line_url":"/filing/0000899243-21-013179#line-1","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Rubius Therapeutics, Inc.","issuer_ticker":"RUBY","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"AFEYAN NOUBAR; Flagship Ventures Fund V, L.P.; Flagship Ventures Fund V General Partner LLC; Flagship Ventures Opportunities Fund I General Partner LLC; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV, L.P.; Flagship Ventures Opportunities Fund I, L.P.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":70000.0,"shares_display":"70,000","price_per_share":29.0,"price_display":"29.00","price_state":"stated","total_value":2030000.0,"total_display":"2,030,000.00","shares_owned_after":2633703.0,"shares_owned_after_display":"2,633,703","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-19","filed_date":"2021-03-23","scope":"insider"},{"id":5454845,"accession":"0000899243-21-005713","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-005713","line_url":"/filing/0000899243-21-005713#line-3","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Kaleido Biosciences, Inc.","issuer_ticker":"KLDO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"AFEYAN NOUBAR; Nutritional Health LTP Fund, L.P.; Nutritional Health LTP Fund General Partner LLC; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Opportunities Fund I, L.P.; Flagship Ventures Fund IV, L.P.; Flagship Ventures Opportunities Fund I General Partner LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":71667.0,"shares_display":"71,667","price_per_share":11.5,"price_display":"11.50","price_state":"stated","total_value":824170.5,"total_display":"824,170.50","shares_owned_after":2982639.0,"shares_owned_after_display":"2,982,639","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-08","filed_date":"2021-02-10","scope":"insider"},{"id":5454842,"accession":"0000899243-21-005713","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-005713","line_url":"/filing/0000899243-21-005713#line-2","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Kaleido Biosciences, Inc.","issuer_ticker":"KLDO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"AFEYAN NOUBAR; Nutritional Health LTP Fund, L.P.; Nutritional Health LTP Fund General Partner LLC; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Opportunities Fund I, L.P.; Flagship Ventures Fund IV, L.P.; Flagship Ventures Opportunities Fund I General Partner LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":71667.0,"shares_display":"71,667","price_per_share":11.5,"price_display":"11.50","price_state":"stated","total_value":824170.5,"total_display":"824,170.50","shares_owned_after":738333.0,"shares_owned_after_display":"738,333","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-08","filed_date":"2021-02-10","scope":"insider"},{"id":5454837,"accession":"0000899243-21-005713","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-005713","line_url":"/filing/0000899243-21-005713#line-1","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Kaleido Biosciences, Inc.","issuer_ticker":"KLDO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"AFEYAN NOUBAR; Nutritional Health LTP Fund, L.P.; Nutritional Health LTP Fund General Partner LLC; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Opportunities Fund I, L.P.; Flagship Ventures Fund IV, L.P.; Flagship Ventures Opportunities Fund I General Partner LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":71666.0,"shares_display":"71,666","price_per_share":11.5,"price_display":"11.50","price_state":"stated","total_value":824159.0,"total_display":"824,159.00","shares_owned_after":1685444.0,"shares_owned_after_display":"1,685,444","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-08","filed_date":"2021-02-10","scope":"insider"},{"id":5275511,"accession":"0000899243-21-004962","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-004962","line_url":"/filing/0000899243-21-004962#line-4","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Evelo Biosciences, Inc.","issuer_ticker":"EVLO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Opportunities Fund I General Partner LLC; Flagship Ventures Fund IV, L.P.; AFEYAN NOUBAR; Flagship Ventures Opportunities Fund I, L.P.; Nutritional Health LTP Fund, L.P.; Flagship Ventures Fund IV-Rx, L.P.; Nutritional Health LTP Fund General Partner LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":46429.0,"shares_display":"46,429","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":696435.0,"total_display":"696,435.00","shares_owned_after":4125461.0,"shares_owned_after_display":"4,125,461","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-02","filed_date":"2021-02-04","scope":"insider"},{"id":5275509,"accession":"0000899243-21-004962","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-004962","line_url":"/filing/0000899243-21-004962#line-3","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Evelo Biosciences, Inc.","issuer_ticker":"EVLO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Opportunities Fund I General Partner LLC; Flagship Ventures Fund IV, L.P.; AFEYAN NOUBAR; Flagship Ventures Opportunities Fund I, L.P.; Nutritional Health LTP Fund, L.P.; Flagship Ventures Fund IV-Rx, L.P.; Nutritional Health LTP Fund General Partner LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":37143.0,"shares_display":"37,143","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":557145.0,"total_display":"557,145.00","shares_owned_after":3207312.0,"shares_owned_after_display":"3,207,312","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-02","filed_date":"2021-02-04","scope":"insider"},{"id":5275505,"accession":"0000899243-21-004962","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-004962","line_url":"/filing/0000899243-21-004962#line-2","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Evelo Biosciences, Inc.","issuer_ticker":"EVLO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Opportunities Fund I General Partner LLC; Flagship Ventures Fund IV, L.P.; AFEYAN NOUBAR; Flagship Ventures Opportunities Fund I, L.P.; Nutritional Health LTP Fund, L.P.; Flagship Ventures Fund IV-Rx, L.P.; Nutritional Health LTP Fund General Partner LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":37143.0,"shares_display":"37,143","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":557145.0,"total_display":"557,145.00","shares_owned_after":1370476.0,"shares_owned_after_display":"1,370,476","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-02","filed_date":"2021-02-04","scope":"insider"},{"id":5275500,"accession":"0000899243-21-004962","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-004962","line_url":"/filing/0000899243-21-004962#line-1","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Evelo Biosciences, Inc.","issuer_ticker":"EVLO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Opportunities Fund I General Partner LLC; Flagship Ventures Fund IV, L.P.; AFEYAN NOUBAR; Flagship Ventures Opportunities Fund I, L.P.; Nutritional Health LTP Fund, L.P.; Flagship Ventures Fund IV-Rx, L.P.; Nutritional Health LTP Fund General Partner LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9285.0,"shares_display":"9,285","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":139275.0,"total_display":"139,275.00","shares_owned_after":791529.0,"shares_owned_after_display":"791,529","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-02","filed_date":"2021-02-04","scope":"insider"},{"id":2857666,"accession":"0000899243-20-018150","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-018150","line_url":"/filing/0000899243-20-018150#line-4","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Evelo Biosciences, Inc.","issuer_ticker":"EVLO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Fund IV-Rx, L.P.; AFEYAN NOUBAR; Flagship Ventures Opportunities Fund I General Partner LLC; Flagship Ventures Opportunities Fund I, L.P.; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1666667.0,"shares_display":"1,666,667","price_per_share":3.75,"price_display":"3.75","price_state":"stated","total_value":6250001.25,"total_display":"6,250,001.25","shares_owned_after":4079032.0,"shares_owned_after_display":"4,079,032","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-29","filed_date":"2020-07-01","scope":"insider"},{"id":2857663,"accession":"0000899243-20-018150","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-018150","line_url":"/filing/0000899243-20-018150#line-3","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Evelo Biosciences, Inc.","issuer_ticker":"EVLO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Fund IV-Rx, L.P.; AFEYAN NOUBAR; Flagship Ventures Opportunities Fund I General Partner LLC; Flagship Ventures Opportunities Fund I, L.P.; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1333333.0,"shares_display":"1,333,333","price_per_share":3.75,"price_display":"3.75","price_state":"stated","total_value":4999998.75,"total_display":"4,999,998.75","shares_owned_after":3170169.0,"shares_owned_after_display":"3,170,169","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-29","filed_date":"2020-07-01","scope":"insider"},{"id":2857660,"accession":"0000899243-20-018150","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-018150","line_url":"/filing/0000899243-20-018150#line-2","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Evelo Biosciences, Inc.","issuer_ticker":"EVLO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Fund IV-Rx, L.P.; AFEYAN NOUBAR; Flagship Ventures Opportunities Fund I General Partner LLC; Flagship Ventures Opportunities Fund I, L.P.; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1333333.0,"shares_display":"1,333,333","price_per_share":3.75,"price_display":"3.75","price_state":"stated","total_value":4999998.75,"total_display":"4,999,998.75","shares_owned_after":1333333.0,"shares_owned_after_display":"1,333,333","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-29","filed_date":"2020-07-01","scope":"insider"},{"id":2857654,"accession":"0000899243-20-018150","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-018150","line_url":"/filing/0000899243-20-018150#line-1","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Evelo Biosciences, Inc.","issuer_ticker":"EVLO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Fund IV-Rx, L.P.; AFEYAN NOUBAR; Flagship Ventures Opportunities Fund I General Partner LLC; Flagship Ventures Opportunities Fund I, L.P.; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":333333.0,"shares_display":"333,333","price_per_share":3.75,"price_display":"3.75","price_state":"stated","total_value":1249998.75,"total_display":"1,249,998.75","shares_owned_after":782244.0,"shares_owned_after_display":"782,244","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-29","filed_date":"2020-07-01","scope":"insider"},{"id":2986784,"accession":"0000899243-20-015630","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-015630","line_url":"/filing/0000899243-20-015630#line-3","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Kaleido Biosciences, Inc.","issuer_ticker":"KLDO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Opportunities Fund I General Partner LLC; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Opportunities Fund I, L.P.; AFEYAN NOUBAR; Flagship Ventures Fund IV, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":666667.0,"shares_display":"666,667","price_per_share":7.5,"price_display":"7.50","price_state":"stated","total_value":5000002.5,"total_display":"5,000,002.50","shares_owned_after":2910972.0,"shares_owned_after_display":"2,910,972","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-04","filed_date":"2020-06-08","scope":"insider"},{"id":2986780,"accession":"0000899243-20-015630","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-015630","line_url":"/filing/0000899243-20-015630#line-2","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Kaleido Biosciences, Inc.","issuer_ticker":"KLDO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Opportunities Fund I General Partner LLC; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Opportunities Fund I, L.P.; AFEYAN NOUBAR; Flagship Ventures Fund IV, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":666667.0,"shares_display":"666,667","price_per_share":7.5,"price_display":"7.50","price_state":"stated","total_value":5000002.5,"total_display":"5,000,002.50","shares_owned_after":1613778.0,"shares_owned_after_display":"1,613,778","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-04","filed_date":"2020-06-08","scope":"insider"},{"id":2986775,"accession":"0000899243-20-015630","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-015630","line_url":"/filing/0000899243-20-015630#line-1","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Kaleido Biosciences, Inc.","issuer_ticker":"KLDO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Opportunities Fund I General Partner LLC; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Opportunities Fund I, L.P.; AFEYAN NOUBAR; Flagship Ventures Fund IV, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":666666.0,"shares_display":"666,666","price_per_share":7.5,"price_display":"7.50","price_state":"stated","total_value":4999995.0,"total_display":"4,999,995.00","shares_owned_after":666666.0,"shares_owned_after_display":"666,666","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-04","filed_date":"2020-06-08","scope":"insider"},{"id":2100821,"accession":"0000899243-20-014188","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0000899243-20-014188","line_url":"/filing/0000899243-20-014188#line-16","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Moderna, Inc.","issuer_ticker":"MRNA","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"AFEYAN NOUBAR; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund IV-Rx, L.P.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":363594.0,"shares_display":"363,594","price_per_share":69.4465,"price_display":"69.45","price_state":"stated","total_value":25250330.721,"total_display":"25,250,330.72","shares_owned_after":22042805.0,"shares_owned_after_display":"22,042,805","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-22","filed_date":"2020-05-26","scope":"insider"},{"id":2100817,"accession":"0000899243-20-014188","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0000899243-20-014188","line_url":"/filing/0000899243-20-014188#line-15","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Moderna, Inc.","issuer_ticker":"MRNA","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"AFEYAN NOUBAR; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund IV-Rx, L.P.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":69254.0,"shares_display":"69,254","price_per_share":69.4465,"price_display":"69.45","price_state":"stated","total_value":4809447.911,"total_display":"4,809,447.91","shares_owned_after":6431512.0,"shares_owned_after_display":"6,431,512","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-22","filed_date":"2020-05-26","scope":"insider"},{"id":2100813,"accession":"0000899243-20-014188","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0000899243-20-014188","line_url":"/filing/0000899243-20-014188#line-14","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Moderna, Inc.","issuer_ticker":"MRNA","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"AFEYAN NOUBAR; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund IV-Rx, L.P.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":56406.0,"shares_display":"56,406","price_per_share":70.1761,"price_display":"70.18","price_state":"stated","total_value":3958353.0966,"total_display":"3,958,353.10","shares_owned_after":21986399.0,"shares_owned_after_display":"21,986,399","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-22","filed_date":"2020-05-26","scope":"insider"},{"id":2100810,"accession":"0000899243-20-014188","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0000899243-20-014188","line_url":"/filing/0000899243-20-014188#line-13","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Moderna, Inc.","issuer_ticker":"MRNA","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"AFEYAN NOUBAR; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund IV-Rx, L.P.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10746.0,"shares_display":"10,746","price_per_share":70.1762,"price_display":"70.18","price_state":"stated","total_value":754113.4452,"total_display":"754,113.45","shares_owned_after":6420766.0,"shares_owned_after_display":"6,420,766","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-22","filed_date":"2020-05-26","scope":"insider"},{"id":2100806,"accession":"0000899243-20-014188","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000899243-20-014188","line_url":"/filing/0000899243-20-014188#line-12","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Moderna, Inc.","issuer_ticker":"MRNA","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"AFEYAN NOUBAR; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund IV-Rx, L.P.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":223314.0,"shares_display":"223,314","price_per_share":65.7661,"price_display":"65.77","price_state":"stated","total_value":14686490.8554,"total_display":"14,686,490.86","shares_owned_after":22603085.0,"shares_owned_after_display":"22,603,085","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-21","filed_date":"2020-05-26","scope":"insider"},{"id":2100803,"accession":"0000899243-20-014188","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000899243-20-014188","line_url":"/filing/0000899243-20-014188#line-11","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Moderna, Inc.","issuer_ticker":"MRNA","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"AFEYAN NOUBAR; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund IV-Rx, L.P.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":121771.0,"shares_display":"121,771","price_per_share":67.1504,"price_display":"67.15","price_state":"stated","total_value":8176971.3584,"total_display":"8,176,971.36","shares_owned_after":22481314.0,"shares_owned_after_display":"22,481,314","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-21","filed_date":"2020-05-26","scope":"insider"},{"id":2100800,"accession":"0000899243-20-014188","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000899243-20-014188","line_url":"/filing/0000899243-20-014188#line-10","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Moderna, Inc.","issuer_ticker":"MRNA","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"AFEYAN NOUBAR; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund IV-Rx, L.P.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42540.0,"shares_display":"42,540","price_per_share":65.7661,"price_display":"65.77","price_state":"stated","total_value":2797689.894,"total_display":"2,797,689.89","shares_owned_after":6538226.0,"shares_owned_after_display":"6,538,226","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-21","filed_date":"2020-05-26","scope":"insider"},{"id":2100798,"accession":"0000899243-20-014188","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000899243-20-014188","line_url":"/filing/0000899243-20-014188#line-9","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Moderna, Inc.","issuer_ticker":"MRNA","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"AFEYAN NOUBAR; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund IV-Rx, L.P.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39082.0,"shares_display":"39,082","price_per_share":68.8144,"price_display":"68.81","price_state":"stated","total_value":2689404.3808,"total_display":"2,689,404.38","shares_owned_after":22442232.0,"shares_owned_after_display":"22,442,232","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-21","filed_date":"2020-05-26","scope":"insider"},{"id":2100795,"accession":"0000899243-20-014188","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-20-014188","line_url":"/filing/0000899243-20-014188#line-8","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Moderna, Inc.","issuer_ticker":"MRNA","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"AFEYAN NOUBAR; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund IV-Rx, L.P.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23199.0,"shares_display":"23,199","price_per_share":67.1504,"price_display":"67.15","price_state":"stated","total_value":1557822.1296,"total_display":"1,557,822.13","shares_owned_after":6515027.0,"shares_owned_after_display":"6,515,027","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-21","filed_date":"2020-05-26","scope":"insider"},{"id":2100792,"accession":"0000899243-20-014188","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-20-014188","line_url":"/filing/0000899243-20-014188#line-7","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Moderna, Inc.","issuer_ticker":"MRNA","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"AFEYAN NOUBAR; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund IV-Rx, L.P.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20492.0,"shares_display":"20,492","price_per_share":70.4564,"price_display":"70.46","price_state":"stated","total_value":1443792.5488,"total_display":"1,443,792.55","shares_owned_after":22421740.0,"shares_owned_after_display":"22,421,740","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-21","filed_date":"2020-05-26","scope":"insider"},{"id":2100789,"accession":"0000899243-20-014188","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-20-014188","line_url":"/filing/0000899243-20-014188#line-6","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Moderna, Inc.","issuer_ticker":"MRNA","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"AFEYAN NOUBAR; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund IV-Rx, L.P.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13408.0,"shares_display":"13,408","price_per_share":71.5141,"price_display":"71.51","price_state":"stated","total_value":958861.0528,"total_display":"958,861.05","shares_owned_after":22408332.0,"shares_owned_after_display":"22,408,332","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-21","filed_date":"2020-05-26","scope":"insider"},{"id":2100785,"accession":"0000899243-20-014188","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-20-014188","line_url":"/filing/0000899243-20-014188#line-5","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Moderna, Inc.","issuer_ticker":"MRNA","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"AFEYAN NOUBAR; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund IV-Rx, L.P.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7443.0,"shares_display":"7,443","price_per_share":68.8143,"price_display":"68.81","price_state":"stated","total_value":512184.8349,"total_display":"512,184.83","shares_owned_after":6507584.0,"shares_owned_after_display":"6,507,584","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-21","filed_date":"2020-05-26","scope":"insider"},{"id":2100784,"accession":"0000899243-20-014188","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-014188","line_url":"/filing/0000899243-20-014188#line-4","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Moderna, Inc.","issuer_ticker":"MRNA","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"AFEYAN NOUBAR; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund IV-Rx, L.P.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3900.0,"shares_display":"3,900","price_per_share":70.4564,"price_display":"70.46","price_state":"stated","total_value":274779.96,"total_display":"274,779.96","shares_owned_after":6503684.0,"shares_owned_after_display":"6,503,684","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-21","filed_date":"2020-05-26","scope":"insider"},{"id":2100781,"accession":"0000899243-20-014188","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-014188","line_url":"/filing/0000899243-20-014188#line-3","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Moderna, Inc.","issuer_ticker":"MRNA","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"AFEYAN NOUBAR; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund IV-Rx, L.P.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2551.0,"shares_display":"2,551","price_per_share":71.5144,"price_display":"71.51","price_state":"stated","total_value":182433.2344,"total_display":"182,433.23","shares_owned_after":6501133.0,"shares_owned_after_display":"6,501,133","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-21","filed_date":"2020-05-26","scope":"insider"},{"id":2100778,"accession":"0000899243-20-014188","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-014188","line_url":"/filing/0000899243-20-014188#line-2","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Moderna, Inc.","issuer_ticker":"MRNA","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"AFEYAN NOUBAR; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund IV-Rx, L.P.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1933.0,"shares_display":"1,933","price_per_share":72.4351,"price_display":"72.44","price_state":"stated","total_value":140017.0483,"total_display":"140,017.05","shares_owned_after":22406399.0,"shares_owned_after_display":"22,406,399","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-21","filed_date":"2020-05-26","scope":"insider"},{"id":2100776,"accession":"0000899243-20-014188","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-014188","line_url":"/filing/0000899243-20-014188#line-1","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Moderna, Inc.","issuer_ticker":"MRNA","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"AFEYAN NOUBAR; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund IV-Rx, L.P.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":367.0,"shares_display":"367","price_per_share":72.4355,"price_display":"72.44","price_state":"stated","total_value":26583.8285,"total_display":"26,583.83","shares_owned_after":6500766.0,"shares_owned_after_display":"6,500,766","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-21","filed_date":"2020-05-26","scope":"insider"},{"id":2456042,"accession":"0000899243-20-013708","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-013708","line_url":"/filing/0000899243-20-013708#line-3","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Axcella Health Inc.","issuer_ticker":"AXLA","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Fund IV, L.P.; Flagship Ventures Opportunities Fund I General Partner LLC; Flagship Ventures Fund IV General Partner LLC; AFEYAN NOUBAR; Flagship Ventures Opportunities Fund I, L.P.; Flagship Ventures Fund IV-Rx, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1900000.0,"shares_display":"1,900,000","price_per_share":4.75,"price_display":"4.75","price_state":"stated","total_value":9025000.0,"total_display":"9,025,000.00","shares_owned_after":2886023.0,"shares_owned_after_display":"2,886,023","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-18","filed_date":"2020-05-20","scope":"insider"}],"next_cursor":"2020-05-18|2456042","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001694665","name":"Evelo Biosciences, Inc.","url":"/issuer/0001694665","role":"Ten percent owner","n_filings":5,"first_seen":"2018-05-15","last_seen":"2023-07-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001633070","name":"Axcella Health Inc.","url":"/issuer/0001633070","role":"Ten percent owner","n_filings":4,"first_seen":"2019-05-15","last_seen":"2022-10-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001709401","name":"Rubius Therapeutics, Inc.","url":"/issuer/0001709401","role":"Ten percent owner","n_filings":1,"first_seen":"2021-03-23","last_seen":"2021-03-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001751299","name":"Kaleido Biosciences, Inc.","url":"/issuer/0001751299","role":"Ten percent owner","n_filings":2,"first_seen":"2020-06-08","last_seen":"2021-02-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001682852","name":"Moderna, Inc.","url":"/issuer/0001682852","role":"Ten percent owner","n_filings":2,"first_seen":"2019-12-11","last_seen":"2020-05-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001485003","name":"Eleven Biotherapeutics, Inc.","url":"/issuer/0001485003","role":"Ten percent owner","n_filings":5,"first_seen":"2014-02-13","last_seen":"2016-09-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001556263","name":"Syros Pharmaceuticals, Inc.","url":"/issuer/0001556263","role":"Ten percent owner","n_filings":1,"first_seen":"2016-07-07","last_seen":"2016-07-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001609809","name":"Seres Therapeutics, Inc.","url":"/issuer/0001609809","role":"Ten percent owner","n_filings":1,"first_seen":"2016-05-27","last_seen":"2016-05-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001503559","retrieved_at":"2026-08-22T00:38:05+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}